ABC | Volume 110, Nº6, June 2018

Short Editorial Arteaga-Fernández & Antunes Prevention of sudden death in hypertrophic cardiomyopathy Arq Bras Cardiol. 2018; 110(6):532-533 1. Teare D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J. 1958;20(1):1-8. 2. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; American Association for Thoracic Surgery; American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Failure Society of America; Heart Rhythm Society; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons. 2011 ACCF/AHA guidelines for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the AmericanCollege of Cardiology Foundation/AmericanHeart Association Task Force on Practice Guidelines. Circulation. 2011;124(24):2761-796. 3. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(39):2733-79. 4. Arteaga E, Ianni BM, Fernandes F, Mady C. Benign outcome in a long- -term follow-up of patients with hypertrophic cardiomyopathy in Brazil. Am Heart J. 2005;149(6):1099-105. 5. Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM. Clinical course of hypertrophic cardiomyopathy in regional United States cohort. JAMA. 1999;281(7):650-5. Erratum in: JAMA. 1999;281(24):2288. 6. Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. J AmColl Cardiol. 2014;64(1):83- 99. Erratum in: J Am Coll Cardiol. 2014;64(11):1188. 7. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA. 2007;298(4):405-12. Erratum in: JAMA. 2007;298(13):1516. 8. Maron BJ, Spirito P, Ackerman MJ, Casey SA, Semsarian C, Estes NA 3rd, et al. Prevention of sudden cardiac death with the implantable cardioverter- defibrillators in children and adolescent with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2013;61(14):1527-35. 9. O’Mahony C, Jichi F, PavlouM, Monserrat L, Anastasakis A, Rapezzi C, et al; Hypertrophic CardiomyopathyOutcomes Investigators. A novel clinical risk predictionmodel for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD). Eur Heart J. 2014;35(30):2010-20. 10. Vriesendorp PA, Schinkel AF, Liebregts M, Theuns DA, van Cleemput J, Ten Cate FJ, et al. Validation of the 2014 European Society of Cardiology Guidelines risk prediction mode for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy. Circ ArrhythmEletrophysiol. 2015;8(4):829-35. 11. Fernandez A, Quiroga A, Ochoa JP, Mysuta M, Casabé JH, Biagetti M, et al. Validation of the 2014 European Society of Cardiology sudden cardiac death risk predictionmodel in hypertrophic cardiomyopathy in a reference center in south America. Am J Cardiol. 2016;118(1):121-6. 12. Maron BJ, Casey SA, Chan RH, Garberich RF, Rowin EJ, Maron MS. Independent assessment of the European Society of Cardiology sudden death risk model for hypertrophic cardiomyopathy. Am J Cardiol. 2015;116(5):757-64. 13. Maron BJ, Maron BS. Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy. Heart Rhythm. 2016;13(5):1155-65. 14. Reis L, Teixeira R, Fernandes A, et al. Prevenção de morte súbita cardíaca emdoentes commiocardiopatia hipertrófica: o quemudou nas guidelines? Arq Bras Cardiol. 2018; 110(6):524-531. 15. de Oliveira Antunes M, Samesima N, Pereira Filho HG, Matsumoto AY, Verrier RL, et al. Exercise-induced quantitative microvolt T-wave alternans in hypertrophic cardiomyopathy. J Electrocardiol. 2017;50(2):184-90. References This is an open-access article distributed under the terms of the Creative Commons Attribution License 533